“Baseline Characteristics of Atopic Dermatitis (AD) and AD Treatments in a Cohort of Adult AD Patients Initiating Dupilumab in a Real-World Registry (PROSE)”. 2020. SKIN The Journal of Cutaneous Medicine 4 (6): s106. https://doi.org/10.25251/skin.4.supp.106.